These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 30530483)

  • 1. Influenza A Virus Infection Induces Muscle Wasting via IL-6 Regulation of the E3 Ubiquitin Ligase Atrogin-1.
    Radigan KA; Nicholson TT; Welch LC; Chi M; Amarelle L; Angulo M; Shigemura M; Shigemura A; Runyan CE; Morales-Nebreda L; Perlman H; Ceco E; Lecuona E; Dada LA; Misharin AV; Mutlu GM; Sznajder JI; Budinger GRS
    J Immunol; 2019 Jan; 202(2):484-493. PubMed ID: 30530483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Forkhead box O3 plays a role in skeletal muscle atrophy through expression of E3 ubiquitin ligases MuRF-1 and atrogin-1 in Cushing's syndrome.
    Kang SH; Lee HA; Kim M; Lee E; Sohn UD; Kim I
    Am J Physiol Endocrinol Metab; 2017 Jun; 312(6):E495-E507. PubMed ID: 28246104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atrogin-1 inhibits Akt-dependent cardiac hypertrophy in mice via ubiquitin-dependent coactivation of Forkhead proteins.
    Li HH; Willis MS; Lockyer P; Miller N; McDonough H; Glass DJ; Patterson C
    J Clin Invest; 2007 Nov; 117(11):3211-23. PubMed ID: 17965779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Iron-induced skeletal muscle atrophy involves an Akt-forkhead box O3-E3 ubiquitin ligase-dependent pathway.
    Ikeda Y; Imao M; Satoh A; Watanabe H; Hamano H; Horinouchi Y; Izawa-Ishizawa Y; Kihira Y; Miyamoto L; Ishizawa K; Tsuchiya K; Tamaki T
    J Trace Elem Med Biol; 2016 May; 35():66-76. PubMed ID: 27049128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms involved in 3',5'-cyclic adenosine monophosphate-mediated inhibition of the ubiquitin-proteasome system in skeletal muscle.
    Gonçalves DA; Lira EC; Baviera AM; Cao P; Zanon NM; Arany Z; Bedard N; Tanksale P; Wing SS; Lecker SH; Kettelhut IC; Navegantes LC
    Endocrinology; 2009 Dec; 150(12):5395-404. PubMed ID: 19837877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myostatin induces degradation of sarcomeric proteins through a Smad3 signaling mechanism during skeletal muscle wasting.
    Lokireddy S; McFarlane C; Ge X; Zhang H; Sze SK; Sharma M; Kambadur R
    Mol Endocrinol; 2011 Nov; 25(11):1936-49. PubMed ID: 21964591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential gene expression of muscle-specific ubiquitin ligase MAFbx/Atrogin-1 and MuRF1 in response to immobilization-induced atrophy of slow-twitch and fast-twitch muscles.
    Okamoto T; Torii S; Machida S
    J Physiol Sci; 2011 Nov; 61(6):537-46. PubMed ID: 21901639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C/EBPβ mediates tumour-induced ubiquitin ligase atrogin1/MAFbx upregulation and muscle wasting.
    Zhang G; Jin B; Li YP
    EMBO J; 2011 Aug; 30(20):4323-35. PubMed ID: 21847090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oligonol, a Low-Molecular Weight Polyphenol Derived from Lychee, Alleviates Muscle Loss in Diabetes by Suppressing Atrogin-1 and MuRF1.
    Liu HW; Chen YJ; Chang YC; Chang SJ
    Nutrients; 2017 Sep; 9(9):. PubMed ID: 28930190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Curcumin prevents lipopolysaccharide-induced atrogin-1/MAFbx upregulation and muscle mass loss.
    Jin B; Li YP
    J Cell Biochem; 2007 Mar; 100(4):960-9. PubMed ID: 17131360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of atrogin-1-targeted proteins during the myostatin-induced skeletal muscle wasting.
    Lokireddy S; Wijesoma IW; Sze SK; McFarlane C; Kambadur R; Sharma M
    Am J Physiol Cell Physiol; 2012 Sep; 303(5):C512-29. PubMed ID: 22673621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atrogin-1 ubiquitin ligase is upregulated by doxorubicin via p38-MAP kinase in cardiac myocytes.
    Yamamoto Y; Hoshino Y; Ito T; Nariai T; Mohri T; Obana M; Hayata N; Uozumi Y; Maeda M; Fujio Y; Azuma J
    Cardiovasc Res; 2008 Jul; 79(1):89-96. PubMed ID: 18346979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of atrogin-1 and MuRF1 prevents dexamethasone-induced atrophy of cultured myotubes.
    Castillero E; Alamdari N; Lecker SH; Hasselgren PO
    Metabolism; 2013 Oct; 62(10):1495-502. PubMed ID: 23866982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endophilin-A Deficiency Induces the Foxo3a-Fbxo32 Network in the Brain and Causes Dysregulation of Autophagy and the Ubiquitin-Proteasome System.
    Murdoch JD; Rostosky CM; Gowrisankaran S; Arora AS; Soukup SF; Vidal R; Capece V; Freytag S; Fischer A; Verstreken P; Bonn S; Raimundo N; Milosevic I
    Cell Rep; 2016 Oct; 17(4):1071-1086. PubMed ID: 27720640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sepsis increases the expression and activity of the transcription factor Forkhead Box O 1 (FOXO1) in skeletal muscle by a glucocorticoid-dependent mechanism.
    Smith IJ; Alamdari N; O'Neal P; Gonnella P; Aversa Z; Hasselgren PO
    Int J Biochem Cell Biol; 2010 May; 42(5):701-11. PubMed ID: 20079455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Skeletal muscle 11beta-HSD1 controls glucocorticoid-induced proteolysis and expression of E3 ubiquitin ligases atrogin-1 and MuRF-1.
    Biedasek K; Andres J; Mai K; Adams S; Spuler S; Fielitz J; Spranger J
    PLoS One; 2011 Jan; 6(1):e16674. PubMed ID: 21304964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Foxo/atrogin induction in human and experimental myositis.
    Lee HK; Rocnik E; Fu Q; Kwon B; Zeng L; Walsh K; Querfurth H
    Neurobiol Dis; 2012 May; 46(2):463-75. PubMed ID: 22590725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Valproic acid attenuates skeletal muscle wasting by inhibiting C/EBPβ-regulated atrogin1 expression in cancer cachexia.
    Sun R; Zhang S; Hu W; Lu X; Lou N; Yang Z; Chen S; Zhang X; Yang H
    Am J Physiol Cell Physiol; 2016 Jul; 311(1):C101-15. PubMed ID: 27122162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TNF induction of atrogin-1/MAFbx mRNA depends on Foxo4 expression but not AKT-Foxo1/3 signaling.
    Moylan JS; Smith JD; Chambers MA; McLoughlin TJ; Reid MB
    Am J Physiol Cell Physiol; 2008 Oct; 295(4):C986-93. PubMed ID: 18701653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cryptotanshinone prevents muscle wasting in CT26-induced cancer cachexia through inhibiting STAT3 signaling pathway.
    Chen L; Yang Q; Zhang H; Wan L; Xin B; Cao Y; Zhang J; Guo C
    J Ethnopharmacol; 2020 Oct; 260():113066. PubMed ID: 32505837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.